Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Personalized Medicine, |
RCV005251181 | SCV000854447 | uncertain significance | not provided | 2018-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535424 | SCV003315340 | uncertain significance | Mucopolysaccharidosis, MPS-II | 2022-08-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 598951). This missense change has been observed in individual(s) with clinical features of mucopolysaccharidosis type II (PMID: 30755392, 34670126). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 83 of the IDS protein (p.Val83Gly). |
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV002535424 | SCV005088923 | likely pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Missense variant in a gene with a low rate of benign missense variation (PP2_Supporting), Multiple lines of computational evidence support a deleterious effect (PP3_Supporting), Patient’s phenotype or family history highly specific for the disease (PP4_Strong) |